Disney may have slowed down on superhero and live-action remakes in 2024, but it's doubling down on its popular franchises in 2025. Only two of Disney's 12 releases this year aren't sequels or ...
Jan 10 (Reuters) - Drugmaker Biogen (BIIB.O), opens new tab will buy all outstanding shares of Sage Therapeutics (SAGE.O), opens new tab that it does not already own for $7.22 apiece, a filing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback